Here are some of the factors that may affect the stock market today.
Before the trading day begins, learn about the number of factors that may influence share prices and the trading climate in stock markets.
Important developments across the globe, the current situation of global markets, sentiments, and the overall news related to stocks or companies are some of the key indicators that you need to consider before investing in the stock market.
Also, the views of brokerages on select stocks and buy/hold/sell recommendations with target prices play a significant role in determining how the markets are going to perform.
* Asian markets opened mixed in trade.
* Dow rebounds from the worst day of 2019 on Wednesday.
* S&P 500 ended 0.3% higher while Nasdaq ended marginally lower.
* European markets closed lower.
* Oil rose post strong US retail sales data after 2 sessions of decline.
* Indian markets are likely to open higher.
STOCKS IN NEWS
RIL: According to sources RIL may buy more cable firms to aid JioFiber plans. An option of partnership with cable companies is also on the table.
Tata Motors: CRISIL has downgraded the company’s long term rating to AA- vs AA
Indiabulls Housing Finance: Moody’s has downgraded Indiabulls Housing Fin Ratings to BA2 from BA1 and changed the outlook to negative.
Yes Bank: Yes Bank mops up Rs1930cr via QIP. The shares were issued at Rs83.55/sh.
BOSCH: The company will shut various plants for 10 days/month in July-September
Cox & Kings: Cox & Kings defaults on payments of Rs149cr due on Aug 14. Yes Bank has invoked 13% pledge promoter stake in the company on July 29.
Central Bank Of India: The bank has cut MCLR by 20 bps across tenures effective from August 15
ONGC: The oil and gas major has lined up Rs 83000 Cr for 25 new oil and gas projects. The company envisages a natural gas output of over 32 bcm by FY24
CLSA on Indiabulls Real: Maintain Buy, Target at 120/share
Morgan Stanley on IGL: Maintain Overweight, Target at 351/share
CITI on Grasim: Maintain Buy, Target at 975/share
Goldman on Thyrocare: Maintain Buy, Target at 570/share
UBS on IPCA: Maintain Sell, Target at 900/share